Literature DB >> 19241016

Reverse-phase diagonal chromatography for phosphoproteome research.

Kris Gevaert1, Joël Vandekerckhove.   

Abstract

We present a gel-free proteomics procedure for the specific isolation of phosphorylated peptides from whole proteome digests. Central is the use of diagonal, reverse-phase chromatography which consists of two consecutive reverse-phase peptide separations with a modification step in between. The latter alters the column retention of affected peptides, thereby allowing their specific isolation from the bulk of nonaffected peptides. To isolate phosphopeptides from complex mixtures, this modification step is a dephosphorylation reaction using a cocktail of broad-spectrum phosphatases. Upon dephosphorylation, peptides undergo a hydrophobic shift and are thereby sorted from in vivo nonphosphorylated peptides. To increase the overall yield of phosphopeptides, a pre-enrichment step was found necessary and to further distinguish true ex-phosphorylated peptides from nonphosphorylated peptides sorted artificially, differential isotope labeling was introduced. The complete COFRADIC sorting procedure is described here.

Mesh:

Substances:

Year:  2009        PMID: 19241016     DOI: 10.1007/978-1-60327-834-8_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

Review 1.  Signal transduction: From the atomic age to the post-genomic era.

Authors:  Jeremy Thorner; Tony Hunter; Lewis C Cantley; Richard Sever
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-10-30       Impact factor: 10.005

Review 2.  Divide and conquer: the application of organelle proteomics to heart failure.

Authors:  Giulio Agnetti; Cathrine Husberg; Jennifer E Van Eyk
Journal:  Circ Res       Date:  2011-02-18       Impact factor: 17.367

3.  Automated enzyme-based diagonal capillary electrophoresis: application to phosphopeptide characterization.

Authors:  Roza Wojcik; Michael Vannatta; Norman J Dovichi
Journal:  Anal Chem       Date:  2010-02-15       Impact factor: 6.986

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.